Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), sold 291,172 shares at $40.22 ($11.7M) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $11.7M BCAB by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.22 | 70,066 | $2.8M | 24.2% |
| 2 | $40.22 | 70,066 | $2.8M | 24.2% |
| 3 | $41.66 | 2,654 | $111K | 0.9% |
| 4 | $41.66 | 2,654 | $111K | 0.9% |
| 5 | $42.24 | 3,070 | $130K | 1.1% |
| 6 | $42.24 | 3,070 |
| $130K |
| 1.1% |
| 7 | $43.50 | 1,100 | $48K | 0.4% |
| 8 | $44.47 | 1,807 | $80K | 0.7% |
| 9 | $44.47 | 1,807 | $80K | 0.7% |
| 10 | $39.36 | 19,673 | $774K | 6.6% |
| 11 | $39.36 | 19,673 | $774K | 6.6% |
| 12 | $40.27 | 12,348 | $497K | 4.3% |
| 13 | $40.27 | 12,348 | $497K | 4.3% |
| 14 | $41.01 | 2 | $82 | 0.0% |
| 15 | $39.33 | 31,349 | $1.2M | 10.6% |
| 16 | $39.33 | 31,349 | $1.2M | 10.6% |
| 17 | $40.08 | 4,068 | $163K | 1.4% |
| 18 | $40.08 | 4,068 | $163K | 1.4% |
| Total | $40.05 avg | 291,172 | $11.7M | 100% |
| Filing → |
| BCAB | BUY | 2022-08-15 | $207K | — | Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |